Macrophage nuclear receptors, metabolism and immune effectors during health and M. tuberculosis infection
Macrophage nuclear receptors, metabolism and immune effectors during health and M. tuberculosis infection
批准号:
10450960
负责人:
Larry S. Schlesinger
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-03-24 至 2021-12-08
关键词:
AgonistAirAllergensAlveolarAlveolar MacrophagesBCL2 geneBiochemical GeneticsBiochemical PathwayBiologicalBiologyCause of DeathCell physiologyClinicalCollectinsDataDevelopmentDrug TargetingEicosanoid ProductionEicosanoidsEnvironmentEventExposure toFailureFamily memberGasesGene ExpressionGenesGenetic TechniquesGenetic TranscriptionGoalsGranulocyte-Macrophage Colony-Stimulating FactorGrowthHealthHomeostasisHumanImmuneImmune Response GenesImmune responseImmune systemImmunityInfectionInflammationInflammatoryInhalationInterleukin-10LaboratoriesLigandsLinkLipidsLungLung infectionsMCL1 geneMaintenanceMediatingMetabolicMetabolismMicrobeModelingMolecularMusMycobacterium tuberculosisNR4A2 geneNuclear ReceptorsPPAR alphaPPAR gammaPTGS2 genePathogenesisPathway interactionsPharmaceutical PreparationsProteinsPulmonary Surfactant-Associated Protein ARegulationResearchRoleRouteS100A8 geneSalesShapesSignal PathwaySignal TransductionTissuesTransforming Growth Factor betaTuberculosisbasecellular developmentcytokineeicosanoid metabolismfamily structureglobal healthhuman modelimmunoregulationin vitro Modelin vivoinhibitor/antagonistknock-downlipid mediatorlipid metabolismmRNA Expressionmacrophagemonocytemouse modelnano-stringpathogenpollutantpre-clinicalprogramsreceptor expressionresponsesurfactanttherapeutic targettranscription factortreatment strategytuberculosis treatment
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Human lungs, while mediating air exchange in the alveoli, are constantly exposed to pollutants, allergens, and
microbes. Resident alveolar macrophages (AMs) must clear insults without damaging the alveoli. Thus, AMs
possess a unique, highly regulated immune response that results in inefficient clearance of some airborne
microbes, especially host-adapted pathogens like Mycobacterium tuberculosis (M.tb), the causative agent of
tuberculosis (TB), a top 10 cause of death worldwide. AM development, maintenance and biology are poorly
understood, especially for human macrophages and in regards to the effect of the local environment, e.g.
surfactant, which lines the alveoli, and locally produced cytokines such as TGFβ. Failure to completely
understand the molecular events underlying AM development and biology creates a critical barrier to
developing new treatment strategies that target the lung. The long-term objective of this ongoing research
program is to identify signaling pathways associated with transcriptional regulators and inflammatory
metabolites that dictate AM biology and how these are co-opted by the host-adapted intracellular pathogen
M.tb, to enhance its growth. New data in the laboratory indicate that M.tb, surfactant proteins and TGFβ
regulate expression of the nuclear receptors (NRs) peroxisome proliferator-activated receptor gamma
(PPARγ), Rev-erbα, Nur77, and Nurr1. NRs are a large family of structurally conserved, ligand activated
transcription factors, which enable macrophages to sense their local environment and shape immune
responses. In this regard, NRs sit at the interface of metabolism (particularly lipid and eicosanoid) and
immunity, and are increasingly recognized as relevant to M.tb pathogenesis, yet are unexplored in the context
of the lung and M.tb. It is critical to understand if/how NRs cooperate to regulate AM biology in ways that
impact responses to M.tb. Expression and function of NRs are tightly regulated to provide a balanced immune
response. The hypothesis for this proposal is that NRs modify eicosanoid metabolism and protective immune
responses, thereby making AMs more susceptible to M.tb and that M.tb augments select endogenous
pathways to further dampen the AM immune response to enhance its survival. The Specific Aims are to: 1)
determine the effect of surfactant and local cytokines on human macrophage NR expression and activity and
how this is modulated by M.tb, 2) characterize newly discovered PPARγ effectors and their regulation of lipid
metabolism during M.tb infection, and 3) determine whether PPARγ, Rev-erbα, Nur77 and Nurr1, as well as
PPARγ effectors, are viable host-directed therapeutic targets for TB. Human AMs and the tractable model of
human blood monocyte-derived macrophages (MDMs), biochemical and genetic techniques, and mouse
models will be used to study the role of NRs, and their effectors, in TB. Since NRs regulate metabolism and
inflammation in a tissue, gene and signal-specific manner, these findings open the door to a completely new
set of biological pathways likely to be critical to host responses in the lung, during health and M.tb infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10431466
-
项目类别:
-
资助金额:$19.99万
-
财政年份:2022
-
负责人:Larry S. Schlesinger
-
依托单位:
Interdisciplinary NexGen TB research Advancement Center (IN-TRAC)
-
批准号:10588203
-
项目类别:
-
资助金额:$115.01万
-
财政年份:2022
-
负责人:Larry S. Schlesinger
-
依托单位:
Clinical Research & Patient Care Core (CRPCC)
-
批准号:10431471
-
项目类别:
-
资助金额:$19.99万
-
财政年份:2022
-
负责人:Larry S. Schlesinger
-
依托单位:
Administrative Core
-
批准号:10588204
-
项目类别:
-
资助金额:$8.61万
-
财政年份:2022
-
负责人:Larry S. Schlesinger
-
依托单位:
Interdisciplinary NexGen TB research Advancement Center (IN-TRAC)
-
批准号:10431465
-
项目类别:
-
资助金额:$119.94万
-
财政年份:2022
-
负责人:Larry S. Schlesinger
-
依托单位:
Clinical Research & Patient Care Core (CRPCC)
-
批准号:10588232
-
项目类别:
-
资助金额:$12.83万
-
财政年份:2022
-
负责人:Larry S. Schlesinger
-
依托单位:
Macrophage nuclear receptors, metabolism and immune effectors during health and M. tuberculosis infection
-
批准号:10457308
-
项目类别:
-
资助金额:$70.68万
-
财政年份:2019
-
负责人:Larry S. Schlesinger
-
依托单位:
Macrophage nuclear receptors, metabolism and immune effectors during health and M. tuberculosis infection- Diversity Supplement
-
批准号:10116937
-
项目类别:
-
资助金额:$3.46万
-
财政年份:2019
-
负责人:Larry S. Schlesinger
-
依托单位:
Expansion of Marmoset Breeding Facilities to Meet Increasing Research Demands
-
批准号:9933536
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2019
-
负责人:Larry S. Schlesinger
-
依托单位:
Macrophage nuclear receptors, metabolism and immune effectors during health and M. tuberculosis infection
-
批准号:10215474
-
项目类别:
-
资助金额:$70.68万
-
财政年份:2019
-
负责人:Larry S. Schlesinger
-
依托单位:
Host bacterial targets mediating immune suppression in pneumonic tularemia
-
批准号:8448670
-
项目类别:
-
资助金额:$60.84万
-
财政年份:2013
-
负责人:Larry S. Schlesinger
-
依托单位:
TB and Innate Immune Regulation of Lung Macrophages
-
批准号:8499656
-
项目类别:
-
资助金额:$6.45万
-
财政年份:2012
-
负责人:Larry S. Schlesinger
-
依托单位:
Host bacterial targets mediating immune suppression in pneumonic tularemia
-
批准号:8233341
-
项目类别:
-
资助金额:$60.46万
-
财政年份:2011
-
负责人:Larry S. Schlesinger
-
依托单位:
Medical Scientist Training Program - Ohio State University
-
批准号:8501526
-
项目类别:
-
资助金额:$29.79万
-
财政年份:2011
-
负责人:Larry S. Schlesinger
-
依托单位:
Medical Scientist Training Program - Ohio State University
-
批准号:8689090
-
项目类别:
-
资助金额:$30.08万
-
财政年份:2011
-
负责人:Larry S. Schlesinger
-
依托单位:
Medical Scientist Training Program - Ohio State University
-
批准号:8078747
-
项目类别:
-
资助金额:$9.84万
-
财政年份:2011
-
负责人:Larry S. Schlesinger
-
依托单位:
Medical Scientist Training Program - Ohio State University
-
批准号:8878287
-
项目类别:
-
资助金额:$19.55万
-
财政年份:2011
-
负责人:Larry S. Schlesinger
-
依托单位:
Medical Scientist Training Program - Ohio State University
-
批准号:8278528
-
项目类别:
-
资助金额:$19.86万
-
财政年份:2011
-
负责人:Larry S. Schlesinger
-
依托单位:
Acquisition of a MALDI-TOF/TOF MS for Glycomic and Lipidomic Research
-
批准号:7794367
-
项目类别:
-
资助金额:$41.5万
-
财政年份:2010
-
负责人:Larry S. Schlesinger
-
依托单位:
Host bacterial targets mediating immune suppression in pneumonic tularemia
-
批准号:7672070
-
项目类别:
-
资助金额:$54.59万
-
财政年份:2009
-
负责人:Larry S. Schlesinger
-
依托单位:
国内基金
海外基金
湍流和化学交互作用对H2-Air-H2O微混燃烧中NO生成的影响研究
-
批准号:51976048
-
项目类别:面上项目
-
资助金额:61.0万元
-
批准年份:2019
-
负责人:邱朋华
-
依托单位: